Alpharix

Alpharix is a vaccine designed to protect against influenza strains, including Influenza Virus B/Austria/1359417/2021-Like Strain and Influenza A/Vic. This intramuscular vaccine is manufactured by GlaxoSmithKline Biologicals S.A. and is intended for seasonal flu prevention.

Alpharix is used to prevent influenza caused by specific strains of the virus. It is typically administered as part of a seasonal flu vaccination program to reduce the risk of infection and its complications. The vaccine targets both Influenza A and B strains, providing broad-spectrum protection against common flu viruses.

Common effects of Alpharix may include mild soreness or redness at the injection site. Some individuals might experience temporary fatigue or low-grade fever following vaccination. These effects are generally mild and short-lived, indicating that the body is building immunity against the flu.

Alpharix should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous flu vaccines or any of its components should consult their healthcare provider before receiving the vaccine. It is important to inform your healthcare provider about any current medications or health conditions.

Alpharix may interact with certain medications or health conditions. It is advisable to discuss any current medications, including immunosuppressants, with a healthcare provider before vaccination. Additionally, individuals with weakened immune systems should consult their healthcare provider to determine the appropriateness of the vaccine.